1Sacks, DB (2006) Carbohydrates. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., pp. 837–867 [Burtis, CA, Ashwood, ER and Bruns, DE, editors]. St Louis, MO: Elsevier Saunders.
2Shaw, JE, Sicree, RA & Zimment, PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4–14.
3Siró, I, Kálpona, E, Kálpona, B, et al. (2008) Functional food. Product development, marketing and consumer acceptance – a review. Appetite 51, 456–467.
4He, M, Yang, H, Han, JH, et al. (2005) Effects of yoghurt supplementation on the growth of preschool children in Beijing suburbs. Biomed Environ Sci 18, 192–197.
5Apostolidis, E, Knon, YI & Shetty, K (2006) Potential of select yogurts for diabetes and hypertension management. J Food Biochem 30, 699–717.
6Epstein, J, Sanderson, IAN & MacDonald, TT (2009) Curcumin as a the therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103, 1545–1557.
7Nisshiyama, T, Mae, T & Kishida, H (2005) Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 53, 959–963.
8Hussein, HK & Abu-Zinadah, OA (2010) Antioxidant effect of curcumin extracts in induced diabetic wister rats. Int J Zool Res 6, 266–276.
9Babu, P & Srinivasan, K (1997) Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol Cell Biochem 166, 169–175.
10Asai, A & Miyazawa, T (2001) Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131, 2932–2935.
11Seo, KII, Choi, MS, Jung, UJ, et al. (2008) Effect of curcumin supplementation on blood glucose, plasma insulin, and homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 52, 995–1004.
12Suryanarayana, P, Saraswat, M, Mrudula, T, et al. (2005) Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophtalmol Vis Sci 6, 2092–2099.
13Sharma, S, Kulkarni, S & Chopra, K (2006) Curcumin the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 33, 940–945.
14Babu, PS & Srinivasan, K (1998) Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181, 87–96.
15Dutta, S, Padhye, S, Priyadarsini, KI, et al. (2005) Antioxidant and antiproliferative activity of curcumin semicarbazone. Bioorg Med Chem Lett 15, 2738–2744.
16Goel, A, Kunnumakkara, AB & Aggarwal, B (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75, 787–809.
17Shankar, T, Shantha, N, Ramesh, H, et al. (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian J Exp Biol 18, 73–75.
18Lao, C, Ruffin, M, Normolle, D, et al. (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10–15.
19Anand, P, Kunnumakkara, AB, Newman, RA, et al. (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807–818.
20Shaik, J, Ankola, DD, Beniwal, V, et al. (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37, 223–230.
21Chen, C, Johnston, TD, Jeon, H, et al. (2009) An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein–Barr virus-transformed human B-cells. Int J Pharm 36, 133–139.
22Maiti, K, Mukherjee, K, Gantait, A, et al. (2007) Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330, 155–163.
23Shoba, G, Joy, D, Joseph, T, et al. (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353–356.
24Trinder, P (1969) Determination of glucose in blood using glucose oxidase with alternative oxygen acceptor. Ann Clin Biochem 6, 24–27.
25The Committee on Enzyme of Scandinavian Society for Clinical Chemistry and Clinical Physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33, 291–306.
26Tietz, NW, Rinker, AD & Shaw, LM (1983) IFCC methods for the measurement of catalytic concentraction of enzymes. Part 5. IFCC method for alkaline phosphatase (orthphosphoric-monoester phosphohydrolase, alkaline optimum, EC 22.214.171.124). J Clin Chem Clin Biochem 21, 731–748.
27Rifai, N & Warnick, GR (2006) Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., pp. 903–981 [Burtis, CA, Ashwood, ER and Bruns, DE, editors]. St Louis, MO: Elsevier Saunders.
28Sugiuchi, H & Okabe, H (2002) Development of homogeneous assay for HDL-C in serum. Risho Byori 50, 226–233.
29Bradford, MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72, 248–254.
30Bergmeyer, HU (1985) Methods of Enzymatic Analysis, 3rd ed., pp. 449–453 [Bergmeyer, HU, Bergmeyer, J and Grassl, M, editors]. Deerfield Beach, FL: Verlag Chemie.
31Dubowski, KM (1962) An o-toluidine method for body fluid glucose determination. Clin Chem 8, 215–235.
32Vies, VD (1953) Two methods for the determination of glycogen in liver. Pharmacol Res 57, 410–416.
33Al-Awwadi, N, Azay, J, Poucheret, P, et al. (2004) Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats. J Agric Food Chem 52, 1008–1016.
34Mori, DM, Baviera, AM, Ramalho, LTO, et al. (2003) Temporal response pattern of biochemical analytes in experimental diabetes. Biotechnol Appl Biochem 38, 183–191.
35Sarkhail, P, Rahmaipour, S, Fadyevatan, S, et al. (2007) Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 56, 261–266.
36Sekiya, M, Yahagi, N, Tamura, Y, et al. (2009) Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islet of Lep ob/ob mice. Biochem Biophys Res Commun 387, 511–515.
37Zelent, D, Najafi, H, Odili, S, et al. (2005) Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans 33, 306–310.
38Pari, L & Murugan, P (2005) Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol 4, 257–274.
39Narayanasamy, A, Namasivayam, N & Radha, K (2003) Effect of tumeric on the enzymes of glucose metabolism in diabetic rats. J Herbs Spices Med Plants 10, 75–84.
40Arun, N & Nalini, N (2002) Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plants Foods Hum Nutr 1, 41–52.
41Fujiwara, H, Hosokawa, M, Zhou, X, et al. (2008) Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res Clin Pract 80, 185–191.
42Mithieux, G, Guignotl, G, Bordet, JC, et al. (2002) Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51, 139–143.
43Kang, C & Kim, E (2010) Synergistic effect of curcumin and insulin on muscle cell glucose metabolism. Food Chem Toxicol 48, 2366–2373.
44Martin, A, Sven-Olof, O, Marja, RT, et al. (2006) Diabetic dyslipidaemia. Curr Opin Lipidol 17, 238–246.
45Soni, Kb & Kuttan, R (1992) Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36, 273–275.
46Na, LX, Zhang, YL, Li, Y, et al. (2011) Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis 21, 526–533.
47Baum, L, Cheung, SK, Mok, VC, et al. (2007) Curcumin effects on blood lipid profile in 6-month human study. Pharmacol Res 56, 509–514.
48Babu, PS & Srinivasan, K (1995) Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 1, 13–21.